TRIGGER-PCI Shows the Challenge of Personalized Antiplatelet Therapy

News Archive | TRIGGER-PCI Shows the Challenge of Personalized Antiplatelet TherapyПодробнее

CYP2C19-Guided Antiplatelet Therapy After PCIПодробнее

Challenges in Dual Antiplatelet Therapy (DAPT) Following Percutaneous Cardiac Intervention (PCI)Подробнее

News Archive | TRIGGER-PCI Shows the Challenge of Personalized Antiplatelet TherapyПодробнее

Optimizing the Benefit of Antiplatelet Therapy in High Risk Post-PCI PatientsПодробнее

Antiplatelet Therapy Post PCI - Roxana Mehran, MDПодробнее

APT: Continuing Dual Antiplatelet Therapy (DAPT) Post-PCIПодробнее

Journal Club - Dual Antiplatelet therapy after PCI in Patients at High Bleeding Risk (MASTER DAPT)Подробнее

Personalized Antiplatelet TherapyПодробнее

DAPT and Triple Therapy: Updates on Latest Evidence for Patients with CAD Undergoing PCIПодробнее

Dual or Triple Therapy Post PCI - Dr. Usman BaberПодробнее

Case 3: PCI Manual - Challenges associated with severe calcificationПодробнее

DAPT After PCI: Controversies and PerspectivesПодробнее

Dual Antiplatelet Therapy after PCI in 2024Подробнее

Advances in Dual Antiplatelet Therapy for Acute Coronary Syndrome (ACS)Подробнее

Antiplatelet Therapy Post Percutaneous Coronary Intervention by Peter M. Pollak, MD | PreviewПодробнее

PRECISE DAPT Score - To Predict Bleeding on Dual Antiplatelet TherapyПодробнее

Management of acute coronary syndrome and antiplatelet useПодробнее

Antiplatelet Therapy in High Bleeding Risk Patients Following PCI, November 6, 2020Подробнее